Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
Do Weight Loss Drugs Like Ozempic Affect Your Breast Health?
Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,
Take a look at a dieter’s weight loss journey using Ozempic
People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can also cause problems. Now that millions of people have successfully lost weight using them,
Mimic Ozempic's Weight Loss Effects Naturally With a Keto-Based Diet
Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as effective as weight loss surgery. While it's not for everyone, it can be a lifesaving option for some.
pulmonologyadvisor
10h
GLP-1 Drug Shortages: How Do They Affect Patients With Diabetes?
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Endocrinology Advisor
13h
GLP-1RA Prescribing Trends, Access Showcased at ObesityWeek® 2024
GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...
1d
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
GlobalData on MSN
1d
Metsera raises $215m in Series B round for weight loss candidates
Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.
2d
Ozempic, Wegovy Linked To Lower Hospitalizations In Alcohol Addicts, Research Shows
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...
Too Old to Operate
13h
Assessing the Impact of GLP-1RAs on Cardiovascular and Renal Outcomes
The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...
News Medical on MSN
23h
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
1d
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
HealthDay on MSN
20h
ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
6d
on MSN
Woman Loses 160lbs on Ozempic, Then Shares Reality of Excess Skin
On October 3, Amy Kane, 35, who once weighed 300 pounds at her heaviest, garnered 1.7 million views (@amyinhalf) after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback